Recebe uma resposta deste empregador
O teu currículo e carta de apresentação, adaptados exatamente ao que estão a contratar.
CSL Behring is seeking an influential communications leader to shape our external affairs and growth strategy. This role sits at the intersection of Corporate Affairs, R&D, Search & Evaluation, Business Development and Commercial teams to drive a global communications program that elevates CSL as a partner of choice for rare disease therapies.
You will lead thought leadership, media engagement and multi-channel campaigns to create high-quality partnering opportunities and strengthen CSL's
Location: APAC, AU, Victoria, Melbourne, CSL Limited Melbourne, EMEA, CH, Kanton Zurich, Schlieren, CSL Vifor, EMEA, CH, Kanton Zurich, Opfikon, CSL Vifor, Americas, US-MA, Waltham, CSL Behring, Americas, US-PA, King of Prussia, CSL Behring
Time Type: Full time
CSL is seeking an influential communications leader to shape and elevate our reputation as a partner of choice for innovators developing therapies for rare and serious diseases. Working at the intersection of Corporate Affairs, Research & Development, Search & Evaluation, Business Development and Commercial teams, this role will develop and execute a global external innovation communications strategy that strengthens CSL's visibility, credibility and appeal among biotech founders, researchers, investors and potential partners.
This is a unique opportunity to directly support CSL's growth strategy by driving thought leadership, executive visibility, media engagement and innovative communications programs that help create high-quality partnering opportunities and strengthen CSL's position across the biotechnology ecosystem.
This role can be based in any of the following locations: Melbourne Australia, King of Prussia/Waltham US or Zurich Switzerland
Closing date for Applications: Friday 23rd October 2026
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.